TheraVir Ltd. (formerly OVCure)

TheraVir develops and produces oncolytic viruses intended to cure cancer.

Biotech start-up company located in the Technion - Israel Institute of Technology. The company was founded principally on the IP and expertise of Prof. Eithan Galun, Director of Hadassah’s Goldyne Savad Institute for Gene Therapy and Prof. Zichria Zakay-Rones and Prof. Amos Panet of the Hebrew University’s Department of Virology.

Charles S. Irving, Dr, COO

P.O. Box 12247
Jerusalem 91121
Israel
Phone: +972-2-677-6190
Fax: +972-2-642-9856

The first product of the company was a non-engineered, selectively replicative, naturally attenuated strain of Newcastle Disease Virus. Published reports have shown that the Newcastle Disease Virus achieves complete remission in cancer patients whose disease could not be addressed with conventional therapy.